au.\*:("MUDALIAR, Sunder")
Results 1 to 25 of 49
Selection :
New oral therapies for type 2 diabetes mellitus : The glitazones or insulin sensitizersMUDALIAR, Sunder; HENRY, Robert R.Annual review of medicine. 2001, Vol 52, pp 239-257, issn 0066-4219Article
Incretin Therapies: Effects Beyond Glycemic ControlMUDALIAR, Sunder; HENRY, Robert R.The American journal of medicine. 2009, Vol 122, Num 6A, issn 0002-9343, S25-S36, SUPArticle
Effects of Incretin Hormones on β-Cell Mass and Function, Body Weight, and Hepatic and Myocardial FunctionMUDALIAR, Sunder; HENRY, Robert R.The American journal of medicine. 2010, Vol 123, Num 3A, issn 0002-9343, S19-S27, SUPArticle
Insulin therapy in type 2 diabetesMUDALIAR, Sunder; EDELMAN, Steven V.Endocrinology and metabolism clinics of North America. 2001, Vol 30, Num 4, issn 0889-8529, vii,935-982 [49 p.]Article
Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectinHUA JIN; MEYER, Jonathan M; MUDALIAR, Sunder et al.Schizophrenia research. 2008, Vol 100, Num 1-3, pp 70-85, issn 0920-9964, 16 p.Article
Efficacy and Safety of Taspoglutide in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Plus Pioglitazone over 24 Weeks: T-Emerge 3 TrialHENRY, Robert R; MUDALIAR, Sunder; KANITRA, Linda et al.The Journal of clinical endocrinology and metabolism. 2012, Vol 97, Num 7, pp 2370-2379, issn 0021-972X, 10 p.Article
Polycystic Ovary Syndrome Is Associated with Tissue-Specific Differences in Insulin ResistanceCIARALDI, Theodore P; ARODA, Vanita; MUDALIAR, Sunder et al.The Journal of clinical endocrinology and metabolism. 2009, Vol 94, Num 1, pp 157-163, issn 0021-972X, 7 p.Article
Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: Effects of pioglitazone and metformin treatmentCIARALDI, Theodore P; ARODA, Vanita; MUDALIAR, Sunder R et al.Metabolism, clinical and experimental. 2013, Vol 62, Num 11, pp 1587-1596, issn 0026-0495, 10 p.Article
Effect of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging studyHENRY, Robert R; LINCOFF, A. Michael; MUDALIAR, Sunder et al.Lancet (British edition). 2009, Vol 374, Num 9684, pp 126-135, issn 0140-6736, 10 p.Article
Insulin and insulin-like growth factor-1 action on human skeletal muscle: Preferential effects of insulin-like growth factor-1 in type 2 diabetic subjectsCIARALDI, Theodore P; CARTER, Leslie; REHMAN, Nabeela et al.Metabolism, clinical and experimental. 2002, Vol 51, Num 9, pp 1171-1179, issn 0026-0495Article
Use of Clinical Markers to Identify Metabolic Syndrome in Antipsychotic-Treated PatientsHUA JIN; MEYER, Jonathan; MUDALIAR, Sunder et al.The Journal of clinical psychiatry. 2010, Vol 71, Num 10, pp 1273-1278, issn 0160-6689, 6 p.Article
Effects of the rapid-acting insulin analog glulisine on Cultured human Skeletal muscle cells: Comparisons with Insulin and insulin-like growth factor ICIARALDI, Theodore P; PHILLIPS, Susan A; CARTER, Leslie et al.The Journal of clinical endocrinology and metabolism. 2005, Vol 90, Num 10, pp 5551-5558, issn 0021-972X, 8 p.Article
Intravenous glargine and regular insulin have similar effects on endogenous glucose output and peripheral activation/deactivation kinetic profilesMUDALIAR, Sunder; MOHIDEEN, Pharis; DEUTSCH, Reena et al.Diabetes care. 2002, Vol 25, Num 9, pp 1597-1602, issn 0149-5992Article
Association of Posttraumatic Stress Disorder With Increased Prevalence of Metabolic SyndromeHUA JIN; LANOUETTE, Nicole M; MUDALIAR, Sunder et al.Journal of clinical psychopharmacology. 2009, Vol 29, Num 3, pp 210-215, issn 0271-0749, 6 p.Article
Young and elderly type 2 diabetic patients inhaling insulin with the AERx® insulin diabetes management system: A pharmacokinetic and pharmacodynamic comparisonHENRY, Robert R; MUDALIAR, Sunder; CHU, Neelima et al.Journal of clinical pharmacology. 2003, Vol 43, Num 11, pp 1228-1234, issn 0091-2700, 7 p.Article
Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscleNIKOULINA, Svetlana E; CIARALDI, Theodore P; MUDALIAR, Sunder et al.Diabetes (New York, NY). 2002, Vol 51, Num 7, pp 2190-2198, issn 0012-1797Article
Selective regulation of cellular and secreted multimeric adiponectin by antidiabetic therapies in humansPHILLIPS, Susan A; KUNG, Jacqueline; CIARALDI, Theodore P et al.American journal of physiology. Endocrinology and metabolism. 2009, Vol 60, Num 3, issn 0193-1849, E767-E773Article
Pharmacodynamic and pharmacokinetic properties of a premixed 85/15 human insulin preparationMUDALIAR, Sunder Raj D; MOHIDEEN, Pharis; BAXI, Sunita C et al.Clinical therapeutics. 2001, Vol 23, Num 3, pp 404-412, issn 0149-2918Article
Impaired muscle glycogen synthase in type 2 diabetes is associated with diminished phosphatidylinositol 3-kinase activationNIKOULINA, Svetlana E; CIARALDI, Theodore P; CARTER, Leslie et al.The Journal of clinical endocrinology and metabolism. 2001, Vol 86, Num 9, pp 4307-4314, issn 0021-972XArticle
Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy VolunteersHENRY, Robert R; CIARALDI, Theodore P; ARMSTRONG, Debra et al.The Journal of clinical endocrinology and metabolism. 2013, Vol 98, Num 8, pp 3446-3453, issn 0021-972X, 8 p.Article
Metabolic and Hormonal Changes Induced by Pioglitazone in Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Clinical TrialARODA, Vanita R; CIARALDI, Theodore P; BURKE, Paivi et al.The Journal of clinical endocrinology and metabolism. 2009, Vol 94, Num 2, pp 469-476, issn 0021-972X, 8 p.Article
Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARγ agonistsCHA, Bong-Soo; CIARALDI, Theodore P; PARK, Kyong-Soo et al.American journal of physiology. Endocrinology and metabolism. 2005, Vol 52, Num 1, pp E151-E159, issn 0193-1849Article
Skeletal muscle GLUT1 transporter protein expression and basal leg glucose uptake are reduced in type 2 diabetesCIARALDI, Theodore P; MUDALIAR, Sunder; BARZIN, Ario et al.The Journal of clinical endocrinology and metabolism. 2005, Vol 90, Num 1, pp 352-358, issn 0021-972X, 7 p.Article
Assessment of capacity to consent to research among older persons with schizophrenia, alzheimer disease, or diabetes mellitus : Comparison of a 3-item questionnaire with a comprehensive standardized capacity instrumentPALMER, Barton W; DUNN, Laura B; APPELBAUM, Paul S et al.Archives of general psychiatry. 2005, Vol 62, Num 7, pp 726-733, issn 0003-990X, 8 p.Article
Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetesEPSHTEYN, Victoria; MORRISON, Katherine; KRISHNASWAMY, Padma et al.Diabetes care. 2003, Vol 26, Num 7, pp 2081-2087, issn 0149-5992, 7 p.Article